世界の粒子同種移植市場インサイト・予測（～2027年）

• 英文タイトル：Global Particulate Allograft Market Insights and Forecast to 2027

• レポートコード：QY2108PAL3655 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料は粒子同種移植の世界市場の現状について調査・分析し、2027年までの市場を予測しました。粒子同種移植の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（整形外科用顆粒、歯科用顆粒）、用途別市場規模（歯科手術、骨手術）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・粒子同種移植の世界市場概要 ・メーカー別の競争状況、市場シェア ・粒子同種移植の種類別市場規模：整形外科用顆粒、歯科用顆粒 ・粒子同種移植の用途別市場規模：歯科手術、骨手術 ・北米の粒子同種移植市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの粒子同種移植市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの粒子同種移植市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の粒子同種移植市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの粒子同種移植市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Biohorizons、BoneEasy、Botiss Biomaterials GmbH、Cowellmedi、Zimmer Biomet、Kyeron、RTI Surgical、Wright Medical ・粒子同種移植のバリューチェーン・販売チャネル分析 ・粒子同種移植の世界市場動向

Market Analysis and Insights: Global Particulate Allograft Market
The global Particulate Allograft market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Particulate Allograft Scope and Segment
Particulate Allograft market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Particulate Allograft market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Orthopedic Granules
Dental Granules

Segment by Application
Dental Surgery
Bone Surgery

By Company
Biohorizons
BoneEasy
Botiss Biomaterials GmbH
Cowellmedi
Zimmer Biomet
Kyeron
RTI Surgical
Wright Medical

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Particulate Allograft Product Introduction
1.2 Market by Type
1.2.1 Global Particulate Allograft Market Size Growth Rate by Type
1.2.2 Orthopedic Granules
1.2.3 Dental Granules
1.3 Market by Application
1.3.1 Global Particulate Allograft Market Size Growth Rate by Application
1.3.2 Dental Surgery
1.3.3 Bone Surgery
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Particulate Allograft Sales Estimates and Forecasts 2016-2027
2.2 Global Particulate Allograft Revenue Estimates and Forecasts 2016-2027
2.3 Global Particulate Allograft Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Particulate Allograft Regions by Sales
2.4.1 Global Top Particulate Allograft Regions by Sales (2016-2021)
2.4.2 Global Top Particulate Allograft Regions by Sales (2022-2027)
2.5 Global Top Particulate Allograft Regions by Revenue
2.5.1 Global Top Particulate Allograft Regions by Revenue (2016-2021)
2.5.2 Global Top Particulate Allograft Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Particulate Allograft Sales by Manufacturers
3.1.1 Global Top Particulate Allograft Manufacturers by Sales (2016-2021)
3.1.2 Global Top Particulate Allograft Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Particulate Allograft Sales in 2020
3.2 Global Particulate Allograft Revenue by Manufacturers
3.2.1 Global Top Particulate Allograft Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Particulate Allograft Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Particulate Allograft Revenue in 2020
3.3 Global Particulate Allograft Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Particulate Allograft Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Particulate Allograft Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Particulate Allograft Sales by Type
4.1.1 Global Particulate Allograft Historical Sales by Type (2016-2021)
4.1.2 Global Particulate Allograft Forecasted Sales by Type (2022-2027)
4.1.3 Global Particulate Allograft Sales Market Share by Type (2016-2027)
4.2 Global Particulate Allograft Revenue by Type
4.2.1 Global Particulate Allograft Historical Revenue by Type (2016-2021)
4.2.2 Global Particulate Allograft Forecasted Revenue by Type (2022-2027)
4.2.3 Global Particulate Allograft Revenue Market Share by Type (2016-2027)
4.3 Global Particulate Allograft Price by Type
4.3.1 Global Particulate Allograft Price by Type (2016-2021)
4.3.2 Global Particulate Allograft Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Particulate Allograft Sales by Application
5.1.1 Global Particulate Allograft Historical Sales by Application (2016-2021)
5.1.2 Global Particulate Allograft Forecasted Sales by Application (2022-2027)
5.1.3 Global Particulate Allograft Sales Market Share by Application (2016-2027)
5.2 Global Particulate Allograft Revenue by Application
5.2.1 Global Particulate Allograft Historical Revenue by Application (2016-2021)
5.2.2 Global Particulate Allograft Forecasted Revenue by Application (2022-2027)
5.2.3 Global Particulate Allograft Revenue Market Share by Application (2016-2027)
5.3 Global Particulate Allograft Price by Application
5.3.1 Global Particulate Allograft Price by Application (2016-2021)
5.3.2 Global Particulate Allograft Price Forecast by Application (2022-2027)

6 North America
6.1 North America Particulate Allograft Market Size by Type
6.1.1 North America Particulate Allograft Sales by Type (2016-2027)
6.1.2 North America Particulate Allograft Revenue by Type (2016-2027)
6.2 North America Particulate Allograft Market Size by Application
6.2.1 North America Particulate Allograft Sales by Application (2016-2027)
6.2.2 North America Particulate Allograft Revenue by Application (2016-2027)
6.3 North America Particulate Allograft Market Size by Country
6.3.1 North America Particulate Allograft Sales by Country (2016-2027)
6.3.2 North America Particulate Allograft Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Particulate Allograft Market Size by Type
7.1.1 Europe Particulate Allograft Sales by Type (2016-2027)
7.1.2 Europe Particulate Allograft Revenue by Type (2016-2027)
7.2 Europe Particulate Allograft Market Size by Application
7.2.1 Europe Particulate Allograft Sales by Application (2016-2027)
7.2.2 Europe Particulate Allograft Revenue by Application (2016-2027)
7.3 Europe Particulate Allograft Market Size by Country
7.3.1 Europe Particulate Allograft Sales by Country (2016-2027)
7.3.2 Europe Particulate Allograft Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Particulate Allograft Market Size by Type
8.1.1 Asia Pacific Particulate Allograft Sales by Type (2016-2027)
8.1.2 Asia Pacific Particulate Allograft Revenue by Type (2016-2027)
8.2 Asia Pacific Particulate Allograft Market Size by Application
8.2.1 Asia Pacific Particulate Allograft Sales by Application (2016-2027)
8.2.2 Asia Pacific Particulate Allograft Revenue by Application (2016-2027)
8.3 Asia Pacific Particulate Allograft Market Size by Region
8.3.1 Asia Pacific Particulate Allograft Sales by Region (2016-2027)
8.3.2 Asia Pacific Particulate Allograft Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Particulate Allograft Market Size by Type
9.1.1 Latin America Particulate Allograft Sales by Type (2016-2027)
9.1.2 Latin America Particulate Allograft Revenue by Type (2016-2027)
9.2 Latin America Particulate Allograft Market Size by Application
9.2.1 Latin America Particulate Allograft Sales by Application (2016-2027)
9.2.2 Latin America Particulate Allograft Revenue by Application (2016-2027)
9.3 Latin America Particulate Allograft Market Size by Country
9.3.1 Latin America Particulate Allograft Sales by Country (2016-2027)
9.3.2 Latin America Particulate Allograft Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Particulate Allograft Market Size by Type
10.1.1 Middle East and Africa Particulate Allograft Sales by Type (2016-2027)
10.1.2 Middle East and Africa Particulate Allograft Revenue by Type (2016-2027)
10.2 Middle East and Africa Particulate Allograft Market Size by Application
10.2.1 Middle East and Africa Particulate Allograft Sales by Application (2016-2027)
10.2.2 Middle East and Africa Particulate Allograft Revenue by Application (2016-2027)
10.3 Middle East and Africa Particulate Allograft Market Size by Country
10.3.1 Middle East and Africa Particulate Allograft Sales by Country (2016-2027)
10.3.2 Middle East and Africa Particulate Allograft Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Biohorizons
11.1.1 Biohorizons Corporation Information
11.1.2 Biohorizons Overview
11.1.3 Biohorizons Particulate Allograft Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Biohorizons Particulate Allograft Product Description
11.1.5 Biohorizons Recent Developments
11.2 BoneEasy
11.2.1 BoneEasy Corporation Information
11.2.2 BoneEasy Overview
11.2.3 BoneEasy Particulate Allograft Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 BoneEasy Particulate Allograft Product Description
11.2.5 BoneEasy Recent Developments
11.3 Botiss Biomaterials GmbH
11.3.1 Botiss Biomaterials GmbH Corporation Information
11.3.2 Botiss Biomaterials GmbH Overview
11.3.3 Botiss Biomaterials GmbH Particulate Allograft Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Botiss Biomaterials GmbH Particulate Allograft Product Description
11.3.5 Botiss Biomaterials GmbH Recent Developments
11.4 Cowellmedi
11.4.1 Cowellmedi Corporation Information
11.4.2 Cowellmedi Overview
11.4.3 Cowellmedi Particulate Allograft Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Cowellmedi Particulate Allograft Product Description
11.4.5 Cowellmedi Recent Developments
11.5 Zimmer Biomet
11.5.1 Zimmer Biomet Corporation Information
11.5.2 Zimmer Biomet Overview
11.5.3 Zimmer Biomet Particulate Allograft Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Zimmer Biomet Particulate Allograft Product Description
11.5.5 Zimmer Biomet Recent Developments
11.6 Kyeron
11.6.1 Kyeron Corporation Information
11.6.2 Kyeron Overview
11.6.3 Kyeron Particulate Allograft Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Kyeron Particulate Allograft Product Description
11.6.5 Kyeron Recent Developments
11.7 RTI Surgical
11.7.1 RTI Surgical Corporation Information
11.7.2 RTI Surgical Overview
11.7.3 RTI Surgical Particulate Allograft Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 RTI Surgical Particulate Allograft Product Description
11.7.5 RTI Surgical Recent Developments
11.8 Wright Medical
11.8.1 Wright Medical Corporation Information
11.8.2 Wright Medical Overview
11.8.3 Wright Medical Particulate Allograft Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Wright Medical Particulate Allograft Product Description
11.8.5 Wright Medical Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Particulate Allograft Value Chain Analysis
12.2 Particulate Allograft Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Particulate Allograft Production Mode & Process
12.4 Particulate Allograft Sales and Marketing
12.4.1 Particulate Allograft Sales Channels
12.4.2 Particulate Allograft Distributors
12.5 Particulate Allograft Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Particulate Allograft Industry Trends
13.2 Particulate Allograft Market Drivers
13.3 Particulate Allograft Market Challenges
13.4 Particulate Allograft Market Restraints

14 Key Findings in The Global Particulate Allograft Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Particulate Allograft Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Orthopedic Granules
Table 3. Major Manufacturers of Dental Granules
Table 4. Global Particulate Allograft Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Particulate Allograft Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Particulate Allograft Sales by Region (2016-2021) & (K Units)
Table 7. Global Particulate Allograft Sales Market Share by Region (2016-2021)
Table 8. Global Particulate Allograft Sales by Region (2022-2027) & (K Units)
Table 9. Global Particulate Allograft Sales Market Share by Region (2022-2027)
Table 10. Global Particulate Allograft Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Particulate Allograft Revenue Market Share by Region (2016-2021)
Table 12. Global Particulate Allograft Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Particulate Allograft Revenue Market Share by Region (2022-2027)
Table 14. Global Particulate Allograft Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Particulate Allograft Sales Share by Manufacturers (2016-2021)
Table 16. Global Particulate Allograft Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Particulate Allograft Revenue Share by Manufacturers (2016-2021)
Table 18. Particulate Allograft Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Particulate Allograft Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Particulate Allograft by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Particulate Allograft as of 2020)
Table 21. Particulate Allograft Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Particulate Allograft Product Offered
Table 23. Date of Manufacturers Enter into Particulate Allograft Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Particulate Allograft Sales by Type (2016-2021) & (K Units)
Table 26. Global Particulate Allograft Sales by Type (2022-2027) & (K Units)
Table 27. Global Particulate Allograft Sales Share by Type (2016-2021)
Table 28. Global Particulate Allograft Sales Share by Type (2022-2027)
Table 29. Global Particulate Allograft Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Particulate Allograft Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Particulate Allograft Revenue Share by Type (2016-2021)
Table 32. Global Particulate Allograft Revenue Share by Type (2022-2027)
Table 33. Particulate Allograft Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Particulate Allograft Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Particulate Allograft Sales by Application (2016-2021) & (K Units)
Table 36. Global Particulate Allograft Sales by Application (2022-2027) & (K Units)
Table 37. Global Particulate Allograft Sales Share by Application (2016-2021)
Table 38. Global Particulate Allograft Sales Share by Application (2022-2027)
Table 39. Global Particulate Allograft Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Particulate Allograft Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Particulate Allograft Revenue Share by Application (2016-2021)
Table 42. Global Particulate Allograft Revenue Share by Application (2022-2027)
Table 43. Particulate Allograft Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Particulate Allograft Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Particulate Allograft Sales by Type (2016-2021) & (K Units)
Table 46. North America Particulate Allograft Sales by Type (2022-2027) & (K Units)
Table 47. North America Particulate Allograft Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Particulate Allograft Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Particulate Allograft Sales by Application (2016-2021) & (K Units)
Table 50. North America Particulate Allograft Sales by Application (2022-2027) & (K Units)
Table 51. North America Particulate Allograft Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Particulate Allograft Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Particulate Allograft Sales by Country (2016-2021) & (K Units)
Table 54. North America Particulate Allograft Sales by Country (2022-2027) & (K Units)
Table 55. North America Particulate Allograft Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Particulate Allograft Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Particulate Allograft Sales by Type (2016-2021) & (K Units)
Table 58. Europe Particulate Allograft Sales by Type (2022-2027) & (K Units)
Table 59. Europe Particulate Allograft Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Particulate Allograft Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Particulate Allograft Sales by Application (2016-2021) & (K Units)
Table 62. Europe Particulate Allograft Sales by Application (2022-2027) & (K Units)
Table 63. Europe Particulate Allograft Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Particulate Allograft Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Particulate Allograft Sales by Country (2016-2021) & (K Units)
Table 66. Europe Particulate Allograft Sales by Country (2022-2027) & (K Units)
Table 67. Europe Particulate Allograft Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Particulate Allograft Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Particulate Allograft Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Particulate Allograft Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Particulate Allograft Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Particulate Allograft Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Particulate Allograft Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Particulate Allograft Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Particulate Allograft Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Particulate Allograft Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Particulate Allograft Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Particulate Allograft Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Particulate Allograft Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Particulate Allograft Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Particulate Allograft Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Particulate Allograft Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Particulate Allograft Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Particulate Allograft Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Particulate Allograft Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Particulate Allograft Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Particulate Allograft Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Particulate Allograft Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Particulate Allograft Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Particulate Allograft Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Particulate Allograft Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Particulate Allograft Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Particulate Allograft Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Particulate Allograft Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Particulate Allograft Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Particulate Allograft Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Particulate Allograft Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Particulate Allograft Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Particulate Allograft Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Particulate Allograft Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Particulate Allograft Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Particulate Allograft Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Particulate Allograft Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Particulate Allograft Revenue by Country (2022-2027) & (US$ Million)
Table 105. Biohorizons Corporation Information
Table 106. Biohorizons Description and Major Businesses
Table 107. Biohorizons Particulate Allograft Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Biohorizons Particulate Allograft Product
Table 109. Biohorizons Recent Developments
Table 110. BoneEasy Corporation Information
Table 111. BoneEasy Description and Major Businesses
Table 112. BoneEasy Particulate Allograft Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. BoneEasy Particulate Allograft Product
Table 114. BoneEasy Recent Developments
Table 115. Botiss Biomaterials GmbH Corporation Information
Table 116. Botiss Biomaterials GmbH Description and Major Businesses
Table 117. Botiss Biomaterials GmbH Particulate Allograft Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Botiss Biomaterials GmbH Particulate Allograft Product
Table 119. Botiss Biomaterials GmbH Recent Developments
Table 120. Cowellmedi Corporation Information
Table 121. Cowellmedi Description and Major Businesses
Table 122. Cowellmedi Particulate Allograft Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Cowellmedi Particulate Allograft Product
Table 124. Cowellmedi Recent Developments
Table 125. Zimmer Biomet Corporation Information
Table 126. Zimmer Biomet Description and Major Businesses
Table 127. Zimmer Biomet Particulate Allograft Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Zimmer Biomet Particulate Allograft Product
Table 129. Zimmer Biomet Recent Developments
Table 130. Kyeron Corporation Information
Table 131. Kyeron Description and Major Businesses
Table 132. Kyeron Particulate Allograft Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Kyeron Particulate Allograft Product
Table 134. Kyeron Recent Developments
Table 135. RTI Surgical Corporation Information
Table 136. RTI Surgical Description and Major Businesses
Table 137. RTI Surgical Particulate Allograft Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. RTI Surgical Particulate Allograft Product
Table 139. RTI Surgical Recent Developments
Table 140. Wright Medical Corporation Information
Table 141. Wright Medical Description and Major Businesses
Table 142. Wright Medical Particulate Allograft Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Wright Medical Particulate Allograft Product
Table 144. Wright Medical Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Particulate Allograft Distributors List
Table 148. Particulate Allograft Customers List
Table 149. Particulate Allograft Market Trends
Table 150. Particulate Allograft Market Drivers
Table 151. Particulate Allograft Market Challenges
Table 152. Particulate Allograft Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Particulate Allograft Product Picture
Figure 2. Global Particulate Allograft Market Share by Type in 2020 & 2027
Figure 3. Orthopedic Granules Product Picture
Figure 4. Dental Granules Product Picture
Figure 5. Global Particulate Allograft Market Share by Application in 2020 & 2027
Figure 6. Dental Surgery
Figure 7. Bone Surgery
Figure 8. Particulate Allograft Report Years Considered
Figure 9. Global Particulate Allograft Sales 2016-2027 (K Units)
Figure 10. Global Particulate Allograft Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Particulate Allograft Revenue 2016-2027 (US$ Million)
Figure 12. Global Particulate Allograft Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Particulate Allograft Sales Market Share by Region (2016-2021)
Figure 14. Global Particulate Allograft Sales Market Share by Region (2022-2027)
Figure 15. North America Particulate Allograft Sales YoY (2016-2027) & (K Units)
Figure 16. North America Particulate Allograft Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Particulate Allograft Sales YoY (2016-2027) & (K Units)
Figure 18. Europe Particulate Allograft Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Particulate Allograft Sales YoY (2016-2027) & (K Units)
Figure 20. Asia-Pacific Particulate Allograft Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Particulate Allograft Sales YoY (2016-2027) & (K Units)
Figure 22. Latin America Particulate Allograft Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Particulate Allograft Sales YoY (2016-2027) & (K Units)
Figure 24. Middle East & Africa Particulate Allograft Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Particulate Allograft Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Particulate Allograft Revenue in 2020
Figure 27. Particulate Allograft Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Particulate Allograft Sales Market Share by Type (2016-2027)
Figure 29. Global Particulate Allograft Revenue Market Share by Type (2016-2027)
Figure 30. Global Particulate Allograft Sales Market Share by Application (2016-2027)
Figure 31. Global Particulate Allograft Revenue Market Share by Application (2016-2027)
Figure 32. North America Particulate Allograft Sales Market Share by Type (2016-2027)
Figure 33. North America Particulate Allograft Revenue Market Share by Type (2016-2027)
Figure 34. North America Particulate Allograft Sales Market Share by Application (2016-2027)
Figure 35. North America Particulate Allograft Revenue Market Share by Application (2016-2027)
Figure 36. North America Particulate Allograft Sales Share by Country (2016-2027)
Figure 37. North America Particulate Allograft Revenue Share by Country (2016-2027)
Figure 38. United States Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 39. Canada Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 40. Europe Particulate Allograft Sales Market Share by Type (2016-2027)
Figure 41. Europe Particulate Allograft Revenue Market Share by Type (2016-2027)
Figure 42. Europe Particulate Allograft Sales Market Share by Application (2016-2027)
Figure 43. Europe Particulate Allograft Revenue Market Share by Application (2016-2027)
Figure 44. Europe Particulate Allograft Sales Share by Country (2016-2027)
Figure 45. Europe Particulate Allograft Revenue Share by Country (2016-2027)
Figure 46. Germany Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 47. France Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 48. U.K. Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 49. Italy Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 50. Russia Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 51. Asia Pacific Particulate Allograft Sales Market Share by Type (2016-2027)
Figure 52. Asia Pacific Particulate Allograft Revenue Market Share by Type (2016-2027)
Figure 53. Asia Pacific Particulate Allograft Sales Market Share by Application (2016-2027)
Figure 54. Asia Pacific Particulate Allograft Revenue Market Share by Application (2016-2027)
Figure 55. Asia Pacific Particulate Allograft Sales Share by Region (2016-2027)
Figure 56. Asia Pacific Particulate Allograft Revenue Share by Region (2016-2027)
Figure 57. China Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 58. Japan Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 59. South Korea Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 60. India Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 61. Australia Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 62. Taiwan Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 63. Indonesia Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 64. Thailand Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 65. Malaysia Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 66. Latin America Particulate Allograft Sales Market Share by Type (2016-2027)
Figure 67. Latin America Particulate Allograft Revenue Market Share by Type (2016-2027)
Figure 68. Latin America Particulate Allograft Sales Market Share by Application (2016-2027)
Figure 69. Latin America Particulate Allograft Revenue Market Share by Application (2016-2027)
Figure 70. Latin America Particulate Allograft Sales Share by Country (2016-2027)
Figure 71. Latin America Particulate Allograft Revenue Share by Country (2016-2027)
Figure 72. Mexico Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 73. Brazil Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 74. Argentina Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 75. Middle East and Africa Particulate Allograft Sales Market Share by Type (2016-2027)
Figure 76. Middle East and Africa Particulate Allograft Revenue Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Particulate Allograft Sales Market Share by Application (2016-2027)
Figure 78. Middle East and Africa Particulate Allograft Revenue Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Particulate Allograft Sales Share by Country (2016-2027)
Figure 80. Middle East and Africa Particulate Allograft Revenue Share by Country (2016-2027)
Figure 81. Turkey Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 82. Saudi Arabia Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 83. UAE Particulate Allograft Revenue (2016-2027) & (US$ Million)
Figure 84. Particulate Allograft Value Chain
Figure 85. Particulate Allograft Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

---